Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Actavis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.

Actavis

Sigurdur Olafsson becomes CEO of Hikma

Sigurdur Olafsson becomes CEO of Hikma His career has also seen him serve in various capacities for Actavis, Pfizer and Omega Farma.

Allergan’s Avycaz breaks Gram-negative pneumonia antibiotic drought

Allergan’s Avycaz breaks Gram-negative pneumonia antibiotic drought Originally developed by Actavis (which was acquired by Allergan in a $25bn deal in 2014), Avycaz combines established cephalosporin antibiotic ceftazidime with avibactam, a novel beta lactamase inhibitor that helps tackle

Teva cuts 25% of workforce, with Israel taking a heavy toll

Teva cuts 25% of workforce, with Israel taking a heavy toll The move comes at a time when Teva is groaning under the weight of nearly $35bn in debt, swelled by its $39bn acquisition of Allergan’s generics business Actavis in 2015, ... be successor laquinimod and an underperformance in its generic drug

Anish Mehta appointed CEO of new women's health business

Anish Mehta appointed CEO of new women's health business Prior to his new role, Mehta has served at Actavis, taking the helm of its European and Middle East business, where he managed a portfolio of pharmaceutical products.

Peter Kelly named managing director of Accord Healthcare UK

Peter Kelly named managing director of Accord Healthcare UK Choice.”. Meanwhile, former Actavis UK managing director Jonathan Wilson has been appointed vice president, West Europe at Accord Healthcare. ... He spent three years heading up Actavis’ UK operations and before that help senior commercial roles at

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics